Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 9,600 shares at $14.29 ($135K) on 2007-11-21, disclosed to the SEC on 2007-11-26.
Scheduled sale ($135k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.91 | 100 | $1K | 1.0% |
| 2 | $13.93 | 300 | $4K | 3.1% |
| 3 | $13.95 | 100 | $1K | 1.0% |
| 4 | $13.96 | 200 | $3K | 2.1% |
| 5 | $13.97 | 300 | $4K | 3.1% |
| 6 | $13.98 | 200 |
| $3K |
| 2.1% |
| 7 | $13.99 | 1,100 | $15K | 11.4% |
| 8 | $14.00 | 800 | $11K | 8.3% |
| 9 | $14.01 | 700 | $10K | 7.3% |
| 10 | $14.02 | 600 | $8K | 6.2% |
| 11 | $14.03 | 400 | $6K | 4.2% |
| 12 | $14.04 | 300 | $4K | 3.1% |
| 13 | $14.05 | 700 | $10K | 7.3% |
| 14 | $14.06 | 300 | $4K | 3.1% |
| 15 | $14.07 | 600 | $8K | 6.3% |
| 16 | $14.08 | 300 | $4K | 3.1% |
| 17 | $14.09 | 400 | $6K | 4.2% |
| 18 | $14.12 | 300 | $4K | 3.1% |
| 19 | $14.13 | 200 | $3K | 2.1% |
| 20 | $14.14 | 100 | $1K | 1.0% |
| 21 | $14.17 | 200 | $3K | 2.1% |
| 22 | $14.20 | 200 | $3K | 2.1% |
| 23 | $14.21 | 100 | $1K | 1.1% |
| 24 | $14.22 | 100 | $1K | 1.1% |
| 25 | $14.23 | 100 | $1K | 1.1% |
| 26 | $14.24 | 100 | $1K | 1.1% |
| 27 | $14.25 | 300 | $4K | 3.2% |
| 28 | $14.26 | 100 | $1K | 1.1% |
| 29 | $14.27 | 100 | $1K | 1.1% |
| 30 | $14.29 | 300 | $4K | 3.2% |
| Total | $14.06 avg | 9,600 | $135K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |